charts are nonsense mostly amatuers are swayed by charts celg is resting just how long it will rest and consolidate is a mystery but it will wake up and then it will go up
first of all im not sure why you are frustrated the market doesnt know who you are..secondly, i hope you have a strategy in place...or you will get killed by the market.....
I am frustrated watching every other stock move up and this dog stall out! This has been going on a long time and I am over it already! If they don't shake things up in their presentations in Rome this week, June 10-13, I am out! I'll buy more REGN and GILD instead of holding on to CELG and watching it continually back up!
i've owned this for 14 years and don't regret it. It's had recent headwinds of many kinds, which others on the board have mentioned. Let me say, that none of the present headwinds are as big as those which faced CELG in the first few years. No one knows where the future price will go or whether and when there will be a market "correction". I have survived several and held, thankfully. First you must know how long you want to hold this stock. If it's a buy and hold forever stock, that's one thing. If you want to be out in a few years or no less than one, that's something else. If your short term, that's another. Length of hold determines your tolerance for price fluctuation short term. Anyone can say it will consolidate here, or go down further, or crash, or rebound. My worthless opinion is that for a hold forever buyer, anything between 100-110 is a buy. Maybe only buy half and wait and see if that "correction" or better price comes, though you may get stuck paying a higher price if the "correction" never materializes. Anyway, that's how I see it. Good luck.
salut_, don't beat yourself up, the CEO was non-stop pumping it after the last Q. Lets hope he wakes up after the next Q.
Indeed. XBI (SPDR's S&P Biotech index fund) was up another 1.75% today, while CELG treaded water. CELG was at $114.7 when I finally switched between the two last Friday. Meanwhile, XBI gained 3.43%.
This pattern of the former outpacing the latter has been true for today, the past week, past month, 3 months, YTD, year and 2 years. Hmm...
Gilead has had "strong concern" about thier hep-c drug pricing. Compare the P/E of CELG to GILD and GILD pays a Div .. the pipe looks good for celgene and that is what I look forward to. Over reliance on Revlimid is a headwind (like the strong dollar) just deal with it for the short term.
Note: I own 2x celg to gild (I'm in this game too).
Sentiment: Strong Buy